What is PFE's market cap?

$175.49B, based on the Nov 4 close of $30.79.

What is PFE's P/E ratio?

40.5× trailing-twelve-month earnings of $4.33B.

Does Pfizer pay a dividend?

Yes. The latest regular dividend was $0.43 per share (ex-date Jul 24), an annualised yield of 5.59%.

How much of PFE is sold short?

137.8M shares, 2.4% of float, as of Oct 15, 2026.

What sector is PFE in?

Healthcare, in the Pharmaceuticals industry.

NYSE · PFEHealthcarePharmaceuticals

Pfizer Inc. (PFE)

$30.79+2.63%

Close Nov 4, 2026 · split-adjusted

Nov 3, 2026$30.00▲ 21.65% in range

Nov 3, 2025Low $23.67 · High $30.67Nov 3, 2026

What changed · written from our data

As of Nov 4, 2026

Pfizer closed at $30.79 on Nov 4, up 2.63% — matching its 52-week closing high. Volume of 50.6M shares was 1.57× its 20-day average (above normal).

Split-adjusted performance: +12.0% over one month, +16.1% over six months, +24.9% over one year.

In the quarter ended Jun 28, 2026, revenue was $15.03B, up 2.6% from a year earlier, with a net margin of -1.6%.

Short interest was 137.8M shares at the Oct 15 settlement, down 8.3% from the prior report (2.4% of float, 4.5 days to cover).

After its Nov 3 report (EPS beat estimates by 18.4%), the stock moved +0.4% from the close before to the close after.

Market cap$175.49B5.70B shares

Revenue · quarter$15.03B+2.6% YoY

Diluted EPS$-0.04−107.8% YoY

P/E · TTM40.5×P/S 2.8×

Net margin-1.6%Gross 72.8%

Dividend yield5.59%$0.43 last paid

52-week range23.67 – 30.790.0% from high

Volume50.6M1.57× 20-day avg

Volatility · 60d20.2%Annualised

Short % of float2.4%4.5 days to cover

Net cash-$51.49BCash $11.70B

Next earnings—Not scheduled

Split-adjusted performance

1W +4.6%1M +12.0%3M +17.5%6M +16.1%YTD +23.7%1Y +24.9%3Y +0.8%5Y −28.3%

Earnings reactions

History →

Nov 3+0.4%

Aug 4+3.1%

May 5+0.9%

Feb 3+0.5%

Close before the report to close after it.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum80

Revenue growth45

Net margin68

Value (low P/E)29

Size99

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short137.8M−8.3% vs prior

Days to cover4.5Settled Oct 15

% of float2.4%

Short vol. 10d40.6%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
PFEPfizer	$30.79	+2.63%	+16.1%	+2.6%	−1.6%	40.5	$175.49B
ABTAbbott Laboratories	$115.51	+5.58%	+33.8%	+13.0%	7.4%	36.8	$199.88B	Compare
VRTXVertex Pharmaceuticals	$549.04	+3.44%	+28.4%	+11.8%	19.0%	35.0	$139.16B	Compare
BMYBristol-Myers Squibb	$64.19	+4.02%	+13.4%	+5.7%	25.6%	14.1	$131.21B	Compare
REGNRegeneron Pharmaceuticals	$930.67	−4.39%	+29.1%	+36.3%	38.1%	20.0	$96.28B	Compare
MRKMerck & Co.	$150.36	+3.93%	+32.4%	+5.1%	−8.0%	116.9	$370.96B	Compare
ABBVABBVIE	$294.83	+3.09%	+43.8%	+10.3%	24.2%	50.4	$521.00B	Compare
TEVATeva Pharmaceutical Industries Limited	$41.85	−0.14%	+15.2%	−0.8%	−13.9%	69.0	$48.81B	Compare
JNJJohnson & Johnson	$276.32	+3.81%	+23.0%	+5.9%	0.8%	41.3	$665.19B	Compare

News about Pfizer

All news →

Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?The Motley Fool · 1d ago▲ Positive Pfizer (PFE) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research · 1d agoNeutral Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?The Motley Fool · Oct 23, 2026▲ Positive Bristol Myers Squibb vs. Pfizer: Consistency vs. Scale in RevenueThe Motley Fool · Oct 22, 2026Neutral Pfizer (PFE) Surpasses Market Returns: Some Facts Worth KnowingZacks Investment Research · Oct 20, 2026Neutral

Quick answers

What does Pfizer do?: Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales.
What is PFE's market cap?: $175.49B, based on the Nov 4 close of $30.79.
What is PFE's P/E ratio?: 40.5× trailing-twelve-month earnings of $4.33B.
Does Pfizer pay a dividend?: Yes. The latest regular dividend was $0.43 per share (ex-date Jul 24), an annualised yield of 5.59%.
How much of PFE is sold short?: 137.8M shares, 2.4% of float, as of Oct 15, 2026.
What sector is PFE in?: Healthcare, in the Pharmaceuticals industry.

About Pfizer

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

HQ: New York, NY75,000 employeesListed Jun 22, 1951pfizer.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology